
Audio By Carbonatix
The Food and Drugs Authority (FDA) has cautioned the populace against the usage of two brands of eyedrops, Ezricare Artificial tears and Delsam Pharma’s Artificial tears.
In a statement, the FDA indicated that the US Center for Disease Control and Prevention (USCDC) has disclosed that the products have caused the death of three persons and vision loss in eight patients.
Therefore, the incident has been classified as an outbreak.

According to the FDA, although the products have not been registered in Ghana anyone who is using any of the products should stop them with immediate effect and “submit them to any of the FDA offices nationwide.”

“Anyone who has used these recalled products and is experiencing any symptoms should contact a healthcare professional immediately.
“Reported symptoms include yellow, green or clear discharge from the eye, eye pain or discomfort, redness, feeling of something in the eye, increase sensitivity to light and blurred visions,” parts of the statement read.

The FDA further assured the public to work earnestly to ensure that only safe and effective medical products are available in Ghana.
Latest Stories
-
Today’s Front pages : Friday, April 10, 2026
24 minutes -
‘We don’t have time’ – Fianoo calls for Schäfer to lead Black Stars temporarily
1 hour -
CAF will not favour any country – President Motsepe
1 hour -
Otto Addo was appointed through the backdoor – Kudjoe Fianoo slams GFA
1 hour -
UG Corporate Football League back from the Easter break
1 hour -
CGI orders motorbike training at tactical school in Kyebi
2 hours -
Sachet water producers in Berekum defy gov’t directives, increase prices
2 hours -
Critical commodities stuck at port, CSOs warn of family planning crisis
2 hours -
Gender Ministry mourns victims of Volta Lake boat tragedy, deploys support for affected families
2 hours -
MPs undergo training on human trafficking and gender dimensions
2 hours -
Don’t expect instant relief – COMAC CEO warns fuel price drops will be gradual
2 hours -
GIS to unveil comprehensive plans to enhance officers’ welfare and infrastructure
3 hours -
Right move, wrong timing? – COMAC CEO questions govt’s delay on fuel price relief
3 hours -
IMF urges Central Banks to keep inflation in check
3 hours -
NRSA stands firm on Toyota Voxy ban despite transport operators’ opposition
3 hours